Physician profile
Steven E Greenstein
NPI 1619046380
$1,179.87
in general payments reported to CMS, 2019-2025
19 companies · $17.38 in 2025
The $17.38 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $195 · 2021: $236 · 2024: $121 · 2025: $17.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $157.38 | 2019-2020 | |
| Abbvie INC. | $154.22 | 2021 | |
| Novo Nordisk INC | $139.01 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $121.05 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $89.02 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $80.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $76.72 | 2019-2021 | |
| Amgen INC. | $70.29 | 2019 | |
| Merck Sharp & Dohme LLC | $60.34 | 2019-2021 | |
| Pfizer INC. | $59.70 | 2019-2021 | |
| Lilly USA, LLC | $47.16 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $21.42 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.59 | 2019 | |
| Abbott Laboratories | $17.38 | 2025 | Cardiomems |
| Amarin Pharma, INC. | $15.68 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $15.27 | 2019 | |
| Boston Scientific Corporation | $12.51 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.45 | 2019 | |
| Seqirus USA INC | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Greenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.